MedTrace Logo

Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese Patients

NCT02873689 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 217

Last updated 2019-07-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the efficacy and safety of dexlansoprazole compared to placebo in relief of daytime and nighttime heartburn over 4 weeks in Chinese participants with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD).

Conditions

  • Heartburn
  • Gastroesophageal Reflux Disease

Interventions

DRUG

Dexlansoprazole

Dexlansoprazole delayed-release capsule

DRUG

Placebo

Dexlansoprazole placebo-matching capsules

Sponsors & Collaborators

Principal Investigators

  • Medical Director · Takeda

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-27
Primary Completion
2018-03-14
Completion
2018-04-19

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02873689 on ClinicalTrials.gov